LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Начало・Списък с акции・Stryker Corp

Stryker Corp

Затворен

СекторЗдравеопазване

316.09 0.8

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

315.23

Максимум

317.64

Ключови измерители
By Trading Economics
Приходи	-104M 745M
Продажби	-1.2B 6B
P/E Средно за сектора	36.252 49.701
EPS	1.93
Дивидентна доходност	1.12
Марж на печалбата	12.375
Служители	56,000
EBITDA	-478M 1.2B

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+23.76% upside

Дивиденти
By Dow Jones
Дивидентна доходност Средно за сектора	1.12% 2.39%
Следващи печалби	30.07.2026 г.
Следваща дата на дивидент	30.07.2026 г.
Следваща дата на екс-дивидент	29.06.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	-5.9B 120B
Предишно отваряне	315.29
Предишно затваряне	316.09

Настроения в новините

By Acuity

54%

46%

279 / 345 Класиране в Healthcare

Stryker Corp Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

30.04.2026 г., 20:41 ч. UTC

Печалби

Stryker 1Q Sales, Profit Rise as it Dealt with Cyberattack

12.03.2026 г., 21:42 ч. UTC

Значими събития в новините

Stryker Says Cyberattack Disruption Is Continuing

11.03.2026 г., 19:18 ч. UTC

Значими двигатели на пазара

Stryker Shares Down After Cyberattack Tied to Iran-Linked Group

29.01.2026 г., 22:05 ч. UTC

Печалби

Stryker Logs Higher 4Q Profit On Sales Gains

30.10.2025 г., 20:36 ч. UTC

Печалби

Stryker Lifts Fiscal Year Sales View After 3Q Revenue Rises

30.04.2026 г., 20:06 ч. UTC

Печалби

Stryker 1Q Organic Net Sales Up 2.4%

30.04.2026 г., 20:06 ч. UTC

Печалби

Stryker Backs FY26 Adj EPS $14.90-Adj EPS $15.10 >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker Still Sees FY26 Organic Sales Grwoth 8% to 9.5%

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q Adj EPS $2.60 >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q EPS $1.93 >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q Net $745M >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q Sales $6.02B >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q Net $745M >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q Adj EPS $2.60 >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q EPS $1.93 >SYK

30.04.2026 г., 20:05 ч. UTC

Печалби

Stryker 1Q Sales $6B >SYK

9.04.2026 г., 20:55 ч. UTC

Печалби

Stryker: Believes Incident Hasn't Had, and Isn't Reasonably Likely to Have, a Material Impact on 2026 Full-Year Guidance >SYK

9.04.2026 г., 20:55 ч. UTC

Печалби

Stryker: Determined Incident Had Material Impact on Operations, With Resulting Impact on Financial Results for 1Q >SYK

9.04.2026 г., 20:55 ч. UTC

Печалби

Stryker: Investigation of Cybersecurity Incident Remains Ongoing >SYK

16.03.2026 г., 00:00 ч. UTC

Значими събития в новините

Hack on U.S. Medical Company Shows Reach of Iran's Cyber Capabilities -- WSJ

30.01.2026 г., 17:03 ч. UTC

Пазарно говорене

Stryker's 4Q Results Signal 2026 Growth -- Market Talk

29.01.2026 г., 21:07 ч. UTC

Печалби

Stryker Sees 2026 Organic Net Sales Growth 8%-9.5%

29.01.2026 г., 21:05 ч. UTC

Печалби

Stryker 4Q Adj EPS $4.47 >SYK

5.11.2025 г., 19:38 ч. UTC

Печалби

This Healthcare Stock Is the Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

5.11.2025 г., 17:00 ч. UTC

Печалби

This Healthcare Stock Is Worst Performer in the S&P 500 Today. Here's Why. -- Barrons.com

30.10.2025 г., 20:21 ч. UTC

Печалби

Stryker Lifts FY Sales View After 3Q Revenue Rises

30.10.2025 г., 20:05 ч. UTC

Печалби

Stryker 3Q Adj EPS $3.19 >SYK

30.10.2025 г., 20:05 ч. UTC

Печалби

Stryker 3Q EPS $2.22 >SYK

30.10.2025 г., 20:05 ч. UTC

Печалби

Stryker 3Q Sales $6.1B >SYK

30.10.2025 г., 20:05 ч. UTC

Печалби

Stryker 3Q Net $859M >SYK

Сравнение с други в отрасъла

Ценова промяна

Stryker Corp Прогноза

Ценова цел

By TipRanks

23.76% нагоре

12-месечна прогноза

Среден 391.67 USD 23.76%

Висок 465 USD

Нисък 315 USD

Според 23 анализатори от Wall Street, предложили 12-месечна ценова цел за Stryker Corp през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

23 ratings

Купи

Задържане

Продай

Според 23 анализатори, дали борсови рейтинги на Stryker Corp през последните 3 месеца.

Настроение

By Acuity

279 / 345 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Stryker Corp

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.